Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study

Background: Carbapenem-resistant Klebsiella pneumoniae (CRKP) appeared recently and now presents a particularly critical problem to hospitalized patients worldwide. We aim to investigate the epidemiology and the risk factors for CRKP colonization and infections, and to evaluate the application perfo...

Full description

Bibliographic Details
Main Authors: Lili Fang, Heping Xu, Xiaoying Ren, Xun Li, Xiaobo Ma, Haijian Zhou, Guolin Hong, Xianming Liang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcimb.2020.00462/full
id doaj-700fa9220143496f8486de75cf047e6a
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Lili Fang
Lili Fang
Lili Fang
Heping Xu
Heping Xu
Heping Xu
Xiaoying Ren
Xiaoying Ren
Xiaoying Ren
Xun Li
Xun Li
Xun Li
Xiaobo Ma
Xiaobo Ma
Xiaobo Ma
Haijian Zhou
Haijian Zhou
Guolin Hong
Guolin Hong
Guolin Hong
Xianming Liang
Xianming Liang
spellingShingle Lili Fang
Lili Fang
Lili Fang
Heping Xu
Heping Xu
Heping Xu
Xiaoying Ren
Xiaoying Ren
Xiaoying Ren
Xun Li
Xun Li
Xun Li
Xiaobo Ma
Xiaobo Ma
Xiaobo Ma
Haijian Zhou
Haijian Zhou
Guolin Hong
Guolin Hong
Guolin Hong
Xianming Liang
Xianming Liang
Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study
Frontiers in Cellular and Infection Microbiology
carbapenems
resistance
Klebsiella pneumonia
carbapenem-resistant Klebsiella pneumonia
MALDI-TOF MS
author_facet Lili Fang
Lili Fang
Lili Fang
Heping Xu
Heping Xu
Heping Xu
Xiaoying Ren
Xiaoying Ren
Xiaoying Ren
Xun Li
Xun Li
Xun Li
Xiaobo Ma
Xiaobo Ma
Xiaobo Ma
Haijian Zhou
Haijian Zhou
Guolin Hong
Guolin Hong
Guolin Hong
Xianming Liang
Xianming Liang
author_sort Lili Fang
title Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study
title_short Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study
title_full Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study
title_fullStr Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study
title_full_unstemmed Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective Study
title_sort epidemiology and risk factors for carbapenem-resistant klebsiella pneumoniae and subsequent maldi-tof ms as a tool to cluster kpc-2-producing klebsiella pneumoniae, a retrospective study
publisher Frontiers Media S.A.
series Frontiers in Cellular and Infection Microbiology
issn 2235-2988
publishDate 2020-09-01
description Background: Carbapenem-resistant Klebsiella pneumoniae (CRKP) appeared recently and now presents a particularly critical problem to hospitalized patients worldwide. We aim to investigate the epidemiology and the risk factors for CRKP colonization and infections, and to evaluate the application performance of MALDI-TOF MS in clustering CRKP.Results: CRKP colonization and infections incidence was 2.7 (35/1,319,427) per 100,000 patient-days. Inpatients in CRKP group had higher medical expense than CSKP group. Inpatients with underlying conditions, particularly with pulmonary diseases, and with antimicrobial use prior to culture within 30 days, especially with carbapenem use, were risk factors for CRKP acquisition. All CRKP isolates were detected producing KPC-2. The MALDI-TOF MS system and PFGE system provided similar results, with a good concordance between the two methods (adjusted Rand's coefficient, 0.846) and a high probability of MALDI-TOF MS to predict PFGE results (Wallace coefficient, 0.908).Conclusions: Underlying conditions, particularly pulmonary diseases, and antimicrobial use prior to culture within 30 days, especially carbapenem use, are risk factors for CRKP acquisition. BlaKPC−2 is the mainstream gene of CRKP in our geographic area of analysis. As only simple sample preparation is needed and the results can be obtained in a short time, MALDI-TOF MS may be considered a probable alternative to PFGE in clustering KPC-2-producing CRKP.
topic carbapenems
resistance
Klebsiella pneumonia
carbapenem-resistant Klebsiella pneumonia
MALDI-TOF MS
url https://www.frontiersin.org/article/10.3389/fcimb.2020.00462/full
work_keys_str_mv AT lilifang epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT lilifang epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT lilifang epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT hepingxu epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT hepingxu epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT hepingxu epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT xiaoyingren epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT xiaoyingren epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT xiaoyingren epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT xunli epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT xunli epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT xunli epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT xiaoboma epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT xiaoboma epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT xiaoboma epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT haijianzhou epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT haijianzhou epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT guolinhong epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT guolinhong epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT guolinhong epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT xianmingliang epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
AT xianmingliang epidemiologyandriskfactorsforcarbapenemresistantklebsiellapneumoniaeandsubsequentmalditofmsasatooltoclusterkpc2producingklebsiellapneumoniaearetrospectivestudy
_version_ 1724678023441022976
spelling doaj-700fa9220143496f8486de75cf047e6a2020-11-25T03:05:32ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882020-09-011010.3389/fcimb.2020.00462545210Epidemiology and Risk Factors for Carbapenem-Resistant Klebsiella Pneumoniae and Subsequent MALDI-TOF MS as a Tool to Cluster KPC-2-Producing Klebsiella Pneumoniae, a Retrospective StudyLili Fang0Lili Fang1Lili Fang2Heping Xu3Heping Xu4Heping Xu5Xiaoying Ren6Xiaoying Ren7Xiaoying Ren8Xun Li9Xun Li10Xun Li11Xiaobo Ma12Xiaobo Ma13Xiaobo Ma14Haijian Zhou15Haijian Zhou16Guolin Hong17Guolin Hong18Guolin Hong19Xianming Liang20Xianming Liang21Department of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, ChinaXiamen Key Laboratory of Genetic Testing, Xiamen, ChinaSchool of Public Health, Xiamen University, Xiamen, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, ChinaXiamen Key Laboratory of Genetic Testing, Xiamen, ChinaSchool of Public Health, Xiamen University, Xiamen, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, ChinaXiamen Key Laboratory of Genetic Testing, Xiamen, ChinaSchool of Public Health, Xiamen University, Xiamen, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, ChinaXiamen Key Laboratory of Genetic Testing, Xiamen, ChinaSchool of Public Health, Xiamen University, Xiamen, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, ChinaXiamen Key Laboratory of Genetic Testing, Xiamen, ChinaSchool of Public Health, Xiamen University, Xiamen, ChinaState Key Laboratory for Infectious Disease Prevention and Control, Chinese Center for Disease Control and Prevention, National Institute for Communicable Disease Control and Prevention, Beijing, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, ChinaDepartment of Clinical Laboratory, The First Affiliated Hospital, School of Medicine, Xiamen University, Xiamen, ChinaXiamen Key Laboratory of Genetic Testing, Xiamen, ChinaSchool of Public Health, Xiamen University, Xiamen, ChinaCenter of Clinical Laboratory, School of Medicine, Zhongshan Hospital, Xiamen University, Xiamen, ChinaInstitute of Infectious Disease, School of Medicine, Xiamen University, Xiamen, ChinaBackground: Carbapenem-resistant Klebsiella pneumoniae (CRKP) appeared recently and now presents a particularly critical problem to hospitalized patients worldwide. We aim to investigate the epidemiology and the risk factors for CRKP colonization and infections, and to evaluate the application performance of MALDI-TOF MS in clustering CRKP.Results: CRKP colonization and infections incidence was 2.7 (35/1,319,427) per 100,000 patient-days. Inpatients in CRKP group had higher medical expense than CSKP group. Inpatients with underlying conditions, particularly with pulmonary diseases, and with antimicrobial use prior to culture within 30 days, especially with carbapenem use, were risk factors for CRKP acquisition. All CRKP isolates were detected producing KPC-2. The MALDI-TOF MS system and PFGE system provided similar results, with a good concordance between the two methods (adjusted Rand's coefficient, 0.846) and a high probability of MALDI-TOF MS to predict PFGE results (Wallace coefficient, 0.908).Conclusions: Underlying conditions, particularly pulmonary diseases, and antimicrobial use prior to culture within 30 days, especially carbapenem use, are risk factors for CRKP acquisition. BlaKPC−2 is the mainstream gene of CRKP in our geographic area of analysis. As only simple sample preparation is needed and the results can be obtained in a short time, MALDI-TOF MS may be considered a probable alternative to PFGE in clustering KPC-2-producing CRKP.https://www.frontiersin.org/article/10.3389/fcimb.2020.00462/fullcarbapenemsresistanceKlebsiella pneumoniacarbapenem-resistant Klebsiella pneumoniaMALDI-TOF MS